The General Hospital Corporation

FDA Regulatory Profile

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
7
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0288-2021Class IIFludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, February 17, 2021